August 28, 2015
Takeda Pharmaceutical has signed an agreement with Nanotherapeutics Inc. to expand its rights to the US biopharma’s Vero cell technology platform, boosting vaccine development opportunities overseas. Takeda said on August 27 that the new deal will expand its commercialization and...read more